GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 117 filers reported holding GENOMIC HEALTH INC in Q3 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $15,860,000 | -45.3% | 548,376 | -51.1% | 0.02% | -51.9% |
Q2 2016 | $29,010,000 | -12.4% | 1,120,296 | -16.2% | 0.05% | -10.3% |
Q1 2016 | $33,118,000 | -34.2% | 1,337,089 | -6.4% | 0.06% | -33.3% |
Q4 2015 | $50,309,000 | +66.4% | 1,429,209 | 0.0% | 0.09% | +47.5% |
Q3 2015 | $30,242,000 | -30.7% | 1,429,209 | -9.0% | 0.06% | -24.4% |
Q2 2015 | $43,641,000 | -24.4% | 1,570,368 | -16.9% | 0.08% | -28.4% |
Q1 2015 | $57,697,000 | -2.3% | 1,888,626 | +2.2% | 0.11% | -7.6% |
Q4 2014 | $59,082,000 | +12.0% | 1,848,047 | -0.9% | 0.12% | +1.7% |
Q3 2014 | $52,775,000 | +38.2% | 1,864,206 | +33.7% | 0.12% | +39.8% |
Q2 2014 | $38,198,000 | +8.4% | 1,394,108 | +4.2% | 0.08% | 0.0% |
Q1 2014 | $35,235,000 | +4.4% | 1,337,715 | +16.0% | 0.08% | +3.8% |
Q4 2013 | $33,750,000 | +32.1% | 1,153,029 | +38.0% | 0.08% | +23.1% |
Q3 2013 | $25,552,000 | +50.4% | 835,566 | +55.9% | 0.06% | +25.0% |
Q2 2013 | $16,993,000 | – | 535,910 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RAMIUS ADVISORS LLC | 430,490 | $29,196,000 | 6.86% |
Baker Brothers Advisors | 9,244,665 | $626,973,000 | 4.26% |
ALPINE ASSOCIATES MANAGEMENT INC. | 789,540 | $53,546,000 | 1.75% |
HARVEST MANAGEMENT LLC | 18,500 | $1,255,000 | 1.75% |
HAVENS ADVISORS LLC | 28,000 | $1,899,000 | 1.73% |
Exane Asset Management | 30,000 | $2,034,600,000 | 1.56% |
EMORY UNIVERSITY | 9,506 | $645,000 | 1.27% |
IndexIQ Advisors LLC | 440,780 | $29,894,000 | 1.06% |
ALPHASIMPLEX GROUP, LLC | 37,537 | $2,546,000 | 0.97% |
Magnetar Financial LLC | 483,143 | $32,767,000 | 0.83% |